P3 Health Partners
PIII
60 hedge funds and large institutions have $17.2M invested in P3 Health Partners in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 20 closing their positions.
0.14% more ownership
Funds ownership: 0.33% → 0.47% (+0.14%)
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
3% less funds holding
Funds holding: 62 → 60 (-2)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
12% less capital invested
Capital invested by funds: $19.6M → $17.2M (-$2.37M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$9.53M |
| 2 |
AC
Armistice Capital
New York
|
+$4.72M |
| 3 |
Millennium Management
New York
|
+$303K |
| 4 |
Goldman Sachs
New York
|
+$278K |
| 5 |
EL
EMFO LLC
Weston,
Florida
|
+$243K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$2.18M |
| 2 |
BlackRock
New York
|
-$1.21M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$710K |
| 4 |
State Street
Boston,
Massachusetts
|
-$329K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$258K |
PIII Hedge Fund Activity: Q2 2024 in Review
60 of the 6,929 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q2 2024, worth a combined $17.2M — down 12% from $19.6M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of PIII and 18 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 14 added.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $9.53M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $2.18M sold.
- 60 institutional investors held P3 Health Partners (PIII) as of Q2 2024, down from 62 in Q1 2024.
- Funds reported $17.2M of P3 Health Partners stock for Q2 2024, down 12% quarter-over-quarter.
- 18 funds opened new P3 Health Partners positions in Q2 2024 and 20 closed out, a net change of -2 holders.
- The largest P3 Health Partners buyer in Q2 2024 was Alyeska Investment Group, an estimated $9.53M added.
- The largest P3 Health Partners seller in Q2 2024 was Janus Henderson Group, an estimated $2.18M sold.
Based on aggregated 13F filings for Q2 2024.